From: Multiresistant bacteria and current therapy - the economical side of the story
Influencing factor | Effect on cost driver | Ref. |
---|---|---|
Early adequate first-line antibiotic therapy | Shorter duration of therapy | Â |
 | Early transfer from ICU to normal ward |  |
 | Shorter LOS |  |
 | Less complications | |
IV-to-oral switch | Shorter i.v. therapy | Â |
 | Earlier discharge and outpatient treatment | |
Adjusted duration of therapy | Less adverse events | Â |
 | Less selection of resistance |  |
 | Less drug cost |  |
 | Shorter LOS | |
Adherence to guidelines | Shorter duration of therapy | Â |
 | Shorter LOS |  |
 | Less complications |  |
 | Less ICU admissions |  |
 | Less HMV |